Company news

Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A (SSE:688393) news

Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A news releases on 6ix. Latest, Sep 10, 2026: "Guangzhou LBP Medicine Science & Technology Co.…

Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A (SSE:688393) news

Press releases & updates

"Guangzhou LBP Medicine Science & Technology Co., Ltd."Announcement on Shareholding Reduction Plan of Shareholder

"Guangzhou LBP Medicine Science & Technology Co., Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction

"Guangzhou LBP Medicine Science & Technology Co., Ltd."Semi-annual Report for 2026

"Guangzhou LBP Medicine Science & Technology Co., Ltd."Announcement on Voluntary Disclosure of the Qualifications Obtained by the Company and its Subsidiaries from April to June 2026

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

Notice on Convening the 2nd Extraordinary General Meeting in 2026

Announcement on Resignation and By-election of Independent Director

Announcement on Implementation of Dividend Distribution for 2025

Hesai Group to Hold Annual General Meeting on June 26, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on Result of Shareholding Reduction by Shareholders

Announcement on Canceling All Remaining Restricted Stocks in the 2022 Restricted Stock Incentive Plan

Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from January to March 2026

Announcement on Change of Accounting Policies

Announcement on Voluntary Disclosure of Cervical Cell Digital Pathology Image Assisted Diagnosis Software Receiving Class III Medical Device Registration Certificate

Announcement on the Estimated Amount of Daily Related Party Transactions in 2026

Announcement on Preliminary Earnings Estimate for 2025

Announcement on Expected Loss in Performance for 2025

Announcement on Shareholding Reduction Plan for Shareholders

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Announcement on Result of Shareholding Reduction by Shareholder

Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from October to December 2025

Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares in Total Reaching 1% Scale

Announcement on Resignation of directors and Senior Management Members and By-election of Non-independent Director

Announcement on Expiration of Plan of Shareholding Reduction by Shareholders and Results of Shareholding Reduction

Announcement on Closing Investment Projects Financed by Extra Raised Funds and Using Residual Raised Funds to Permanently Supplement Current Capital

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

Report for Q3 2025

Announcement on Convening the Q3 2025 Performance Briefing

Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from July to September 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

Announcement on the Temporary Adjustment of the Use of Idle Sites in Certain Fundraising Investment Projects

Announcement on Voluntary Disclosure of Obtaining EU CE Certification for the Company's Products

Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Real-time Fluorescence PCR)

Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from April to June 2025

Indicative Announcement on Report on Results of Shareholder's Inquiry Transfer and Equity Change Reaching 1% of Shareholders with Over 5% Shares

Indicative Announcement on Transfer Pricing for Shareholder Inquiry

Shareholders' Inquiry Transfer Plan

Announcement on Implementation of Dividend Distribution for 2024

Announcement on Resolution of the 8th Meeting of the 4th Board of Supervisors and Election of Chairman of the 4th Board of Supervisors

Announcement on Resolution of the 2024 Annual General Meeting

Announcement on Resolution of the 7th Meeting of the 4th Board of Supervisors

2024 Annual Report

Announcement on Equity Change of Shareholders with Over 5% Shares Reaching 1% and Results of Shareholding Reduction

Announcement on Change of the Signing Accountant

Indicative Announcement on Equity Change Resulting from Shareholding Reduction of Shareholders with Over 5% Shares to 5%

Announcement on Preliminary Earnings Estimate for 2024

Indicative Announcement on Changes in Shareholder's Equity

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from October to December 2024